JW Pharmaceutical Corp banner

JW Pharmaceutical Corp
KRX:001067

Watchlist Manager
JW Pharmaceutical Corp Logo
JW Pharmaceutical Corp
KRX:001067
Watchlist
Price: 45 000 KRW 5.14% Market Closed
Market Cap: ₩558.8B

Wall St Price Targets

Price Targets Summary
JW Pharmaceutical Corp

There are no price targets for JW Pharmaceutical Corp.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
JW Pharmaceutical Corp Competitors:
Price Targets
8155
Allied Circuit Co Ltd
-11% Downside

Revenue
Forecast

5% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 7%.

Gross Profit
Forecast

8% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
8% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 1 year is -7%.

Operating Income
Forecast

19% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
19% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 3 years is 11%.

Pre-Tax Income
Forecast

N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 13%.

Net Income
Forecast

N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is JW Pharmaceutical Corp's stock price target?
Not Available

JW Pharmaceutical Corp does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for JW Pharmaceutical Corp?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 7%.

What is the Gross Profit forecast for JW Pharmaceutical Corp?
Projected CAGR
-7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 1 year is -7%.

What is the Operating Income forecast for JW Pharmaceutical Corp?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 3 years is 11%.

What is the Pre-Tax Income forecast for JW Pharmaceutical Corp?
Projected CAGR
13%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 13%.

What is the Net Income forecast for JW Pharmaceutical Corp?
Projected CAGR
20%

The compound annual growth rate for Net Income over the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett